Stay up to date

Latest press releases

02/20/2025

Wörwag Pharma: Dynamic Growth and Expanded Market Presence

Böblingen, February 20, 2025 – The family-owned company Wörwag Pharma achieved an organic revenue growth of 10.5% in 2024, significantly outperforming…

Read press information

11/29/2024

Wörwag Pharma celebrates 25th anniversary in Slovakia

Bratislava, November 29, 2024 – Wörwag Pharma celebrates its 25th anniversary in the Slovak market this year. CEO Lucia Frzonová looks back on the…

Read press information

11/25/2024

Thank you for 25 years of Taza!

For 25 years, the Wörwag family and the Herrnhuter Missionshilfe e.V. have been committed to education and the fight against poverty in Tanzania. In…

Read press information

02/22/2024

Wörwag Pharma: success instead of bottle necks

Böblingen, February 22, 2024 – Wörwag Pharma closed the 2023 financial year with an organic sales growth of 7.6 percent – despite the tense situation…

Read press information

01/22/2024

Mauermann becomes Wörwag Pharma Production

Böblingen, January 22, 2024 – With the renaming of the most recent investment Mauermann Arzneimittel GmbH & Co. KG, Wörwag Pharma is taking the next…

Read press information

03/16/2023

Wörwag Pharma invests in further growth

Böblingen, March 16, 2023 – The Böblingen-based pharmaceutical and family-owned company Wörwag Pharma closed the 2022 financial year with an increase…

Read press information

Your contact

Monika Wörwag

Director Corporate Communications

press@woerwagpharma.com

Information for media representatives

Journalists and editors may use the images available here free of charge and for editorial purposes only, provided they cite "Wörwag Pharma" as the source. Graphic changes are not permitted. Please send your free specimen copies to press@woerwagpharma.com.